Essays on responsible research.
Platform | ![]() | Pricing | Only free issues | Publishes | Daily |
---|---|---|---|---|---|
Issues | 36 | Subscribers | Read | biosafetynow.substack.com |
Curious about how many subscribers Biosafety Now has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
Below is oral and submitted testimony given by Richard Ebright for the US Senate Hearing "Origins of COVID-19: An Examination of Available Evidence.” Prof. Ebright is Board of Governors Professor of Chemistry and Chemical Biology at Rutgers...
Stuart Newman and Felipe Cabello sent this letter to The Nation contesting the June 21 opinion article by Gregg Gonsalves and John P. Moore, “The New York Times is Failing its Readers Badly on Covid.” Newman is a cell and evolutionary biolo...
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read this entire series here.
Since January 2024, Dr. Wain-Hobson has written weekly essays for Biosafety Now discussing risky research in virology. You can read this entire series here.
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Essays on responsible research.
Simon Wain-Hobson is an emeritus professor of Virology at the Institute Pasteur, Paris. With a PhD from the University of Oxford he moved to France in 1980. His team were the first to sequence the genome of the virus that causes AIDS.
Professor of Genetics, Rutgers University more
You can find recent issues that have been published by Biosafety Now on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Biosafety Now, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biosafety Now as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biosafety Now using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Biosafety Now. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.